. In Salmonella, the toxin TacT is involved in pathogenesis and persistence inside macrophages 4, 5 , however, as with most toxin-antitoxin modules, the overarching physiological role of other GNAT-toxinantitoxin (GNAT-TA) toxins remains under debate 2, 6 . AtaR/AtaT and TacA/TacT from Escherichia coli and Salmonella are well-studied toxin-antitoxin modules involving GNAT enzymes 4, 7 . TacT acetylates Gly-tRNA . The E. coli ItaT toxin from the itaRT operon, also inhibits translation elongation by acetylating the Ile-tRNA Ile9 . AtaT, however, acetylates initiation Met-tRNA fMet before formylation 7 , interfering with the assembly of the 30S pre-initiation complex and inhibiting translation. In all these cases, the mechanisms of acetyltransfer, target selection as well as neutralization and transcription autoregulation remain elusive.
The antitoxin AtaR binds and neutralizes AtaT via its intrinsically disordered C-terminal region (IDR), sufficient to counteract the action of AtaT in vivo 10 . IDRs moonlight in the regulation of toxin-antitoxin modules as toxin inhibitors and transcriptional regulatory elements 11 . They connect toxin neutralization with transcriptional repression, through the formation of a repressor complex that involves the toxin as an essential cofactor [11] [12] [13] . In addition, IDRs can modulate the promoter availability to the RNA polymerase, acting as entropic barriers to full repression and their disordered nature ensures rapid turnover, an absolute requirement in some systems 14 .
Here we show the interaction of AtaT with Met-tRNA fMet involves a positive patch formed by both subunits of the dimer. For neutralization, AtaR traps AtaT in a heterohexameric AtaT-AtaR 2 -AtaR 2 -AtaT complex that is formed coupled to AtaT synthesis, precluding toxin dimerization (which is the active state of AtaT). The neutralized complex shows a non-covalent cross-linked arrangement with AtaR wrapped around an inactive AtaT monomer and blocking all functional hotspots of the toxin. The formation of a complex with this architecture, is crucial for transcription autoregulation. It provides a direct feedback between the level of AtaT actively synthetized and the operon repression, in the form of a complex that involves a pre-mature form of the toxin. It also ensures that when levels of active dimeric AtaT increase, the dimer triggers de-repression of the operon and the synthesis of AtaR to neutralize the toxin.
Results

Structure of the toxin AtaT
Y144F
. The structure of a variant of AtaT (Y144F) with limited catalytic activity, AtaT Y144F (Fig. 1a,b and Supplementary Fig. 1a ), resembles that of its homologous TacT from Salmonella (5FVJ) and KacT (PDBID 5XUN) from Klebsiella pneumoniae 4, 15 , superimposing with a core r.m.s. deviation of (1.2 Å and 0.8 Å, respectively). AtaT has the typical GNAT topology, a central seven-stranded β -sheet bounded by four α -helices with α -helix α 3 containing the (Q/R-x-x-G-x-G/A) signature motif of the family (Fig. 1a,b) . AtaT Y144F is a compact dimer with an interface of roughly 800 Å 2 involving the C-terminal cap of α -helix α 2 (including G125 and V126) and the central β 3-β 4 β -strands. At the dimer interface the β 3-β 4 β -hairpin bends almost 30° away from the main axis of the protein and together with α -helix α 4 and the α -helix α 1 of the other monomer form a positive cleft that leads to the active site of the enzyme where acetyl-CoA binds ( Fig. 1b and Supplementary Fig. 1b ).
Ac-CoA binding aligns the active site of AtaT Y144F . Acetyl-CoA interacts strongly with AtaT Y144F . Isothermal titration calorimetry (ITC) shows AtaT Y144F has an affinity of 245 nM for ac-CoA (Supplementary Fig. 2a and Supplementary Table 1) . ITC shows a twofold decrease in the affinity of AtaT Y144F for CoA (K d = 491 nM) (Supplementary Fig. 2b and Supplementary Table 1) . Considering the intracellular levels of ac-CoA and CoA, are in the range of 20-600 µ M 16, 17 , additional structural factors are probably involved in the CoA/ac-CoA turnover. The interaction of the pantetheine arm and the acetyl group of ac-CoA with GNAT enzymes is very conserved. In the complex with AtaT Y144F , this part of ac-CoA is accommodated in a V-shaped cavity formed by a bulge between the parallel β -strands β 4 and β 5 and α -helix α 3, which contains the catalytic Tyr (Fig. 1a,b) , resembling the way ac-CoA interacts with TacT or KacT ( Supplementary Fig. 1c ).
Beyond this point TacT and KacT interact with the cofactor in a different way. Substitutions of H142 and H143 of TacT by S145 and L146 in AtaT flipped 180° the relative orientation of the 3′ -phosphate and the adenine base with respect to TacT or KacT. As a result, the 3′ -phosphate of ac-CoA tethers α -helix α 3 to the P-loop, hydrogen-bonding T141 and S145. These interactions of the head group of ac-CoA with α -helix α 3 either in one orientation or the other is probably a key factor in the alignment of the catalytic residues of AtaT in the active site ( Supplementary Fig. 1c) . Indeed, the S145H/ L146H double substituted version of AtaT remains toxic suggesting that stabilization of the head group of ac-CoA, rather than its orientation, is important for the catalysis (Supplementary Fig. 1d ).
AtaT binds Met-tRNA fMet at the dimer interface. AtaT binds MettRNA fMet with ~2 μ M affinity and 1:1 stoichiometry (Supplementary Fig. 2c and Supplementary Table 1) . A cleft formed at the dimer interface of AtaT defines a large positive surface involving R71, K79, K86, H129 and K165 of one monomer; together with H34, R37, Q38, R40, R45 and R95 of the other (Fig. 1c) . This basic patch is probably the main contact point for Met-tRNA fMet leading directly toward the catalytic Y144 and the acetyl group of ac-CoA ( Supplementary  Fig. 1e ). AtaT is very specific for Met-tRNA fMet7 and de-amino acylation precludes tRNA fMet binding ( Supplementary Fig. 2c,d ). Moreover, AtaT does not acetylate Met-tRNA Met 7 (the tRNA Met used fMet binding site mapping-the AtaT Y144F dimer interface involves R71, K79, K86, H129 and K165 of one monomer; and H34, R37, Q38, R40, R45 and R95 of the other. Catalytic residue Y144 is indicated in italic. d, Ten-fold dilutions of overnight cultures of E. coli strains transformed with pBAD33 vector or derivatives expressing ataT, or the ataT mutants encoding the substitutions R45E, R71E, K86E, S101E, H129E, H141E, Y144F and K165E (as well as all the corresponding Ala substitutions, R45A, R71A, K86A, S101A, H129A, H141A and K165A) under repression or induction conditions. The control substitutions at S101 and H141 show no effect on toxicity. WT, wild type.
in elongation) suggesting that Met-tRNA fMet is anchored to AtaT in at least two sites.
We substituted six residues covering most of the positive patch (R45E, R71E, K86A, H129E, Y144F and K165A) and two additional residues (S101E and H141E) outside this region as controls. Figure 1d shows the modifications on R45, R71 and H129 affect the toxicity of the enzyme. Substitutions at R71 have the strongest effect, resulting in a version of AtaT that behaves almost as the catalytically impaired AtaT Y144F (suggesting that R71 is directly interacting with Met-tRNA Met ). In addition, the K86E modification also shows some effect albeit a minor one.
The emerging interaction surface indicates the dimer interface has a major role in the function of AtaT. To challenge this hypothesis, we generated a V126D substitution in AtaT (AtaT V126D ) that could potentially preclude dimerization ( Supplementary Fig. 1f-h ). Size exclusion chromatography (SEC) shows AtaT V126D is a monomer in solution ( Supplementary Fig. 1f,g ) and circular dichroism spectroscopy confirmed the structural integrity of AtaT V126D ( Supplementary Fig. 2e ). In addition, ITC titrations with ac-CoA showed that the monomeric enzyme binds the cofactor with a similar affinity as the dimer (Supplementary Fig. 2f and Supplementary Table 1) . Supplementary Fig. 1h shows that AtaT V126D could be expressed in E. coli without affecting growth, indicating that the AtaT V126D monomer is non-toxic. These results support the notion that Met-tRNA fMet binds AtaT in this positive groove formed by both monomers, hence target binding depends on the toxin oligomerization, highlighting the role of the dimer as the active enzyme form.
AtaR intrinsically disordered region neutralizes AtaT. The mechanisms of toxin neutralization by their cognate antitoxin are largely diverse [18] [19] [20] [21] [22] [23] . AtaR belongs to the ribbon-helix-helix (RHH) family that are typically dimers in solution [24] [25] [26] . The structure of AtaR shows the RHH dimer adopts an elongated conformation (Fig. 2a) . The second α -helix of each monomer extends toward the C terminus from V32 to S69 (S73 to M88 are not visible and are presumably disordered). In this arrangement the AtaR dimer shows a scissorlike fashion (Fig. 2a) spanning 112° between each α -helix.
The C-terminal α -helix is stabilized in the structure by lattice contacts with symmetry-related molecules ( Supplementary  Fig. 3a) . On its own, the C-terminal region of AtaR (AtaR A44-M88 ) or shorter versions from S60 to M88 (AtaR S60-M88 ) are largely disordered in solution as shown by circular dichroism spectroscopy ( Supplementary Fig. 3b ). The circular dichroism spectra of both, AtaR A44-M88 and AtaR   S60-M88 , show a lack of secondary structure and a distinctive minimum at 205 nm typical of disordered proteins. Moreover, AtaR A44-M88 lacks an observable transition from native to denatured state, also a signature feature of IDRs ( Supplementary Fig. 3b ).
In vivo, AtaR A44-M88 neutralizes AtaT 10 . Figure 2b ,c shows the 3.2 kDa fragment AtaR S60-M88 also neutralized AtaT and rescued translation in vitro (however, this fragment failed to neutralize AtaT in vivo, Supplementary Fig. 3c ). Furthermore, we tested the effects on toxin neutralization, of trimming AtaR from the C terminus (Fig. 2d) . Removing the last six residues of AtaR (K83 to M88) has a strong effect on growth and when this is extended to nine residues (R80 to M88) neutralization severely drops. These results indicate the neutralization region of AtaR involves almost entirely the IDR.
Structure of the AtaR-neutralized AtaT dimer. We used AtaR A44-M88 to gain further insights into the mechanism of AtaT neutralization. AtaT Y144F interacts with AtaR A44-M88 with an affinity of 367 nM, lower than the affinity for the full length AtaR (K d = 29 nM) ( Supplementary Fig. 2g ,h and Supplementary Table 1) . Despite the tenfold drop in affinity, AtaR A44-M88 efficiently counteracted the action of AtaT as a translation inhibitor (Fig. 2c) . The structure AtaR A44-M88 in complex with AtaT Y144F (Fig. 3a and Supplementary  Fig. 3d ) showed the intrinsically disordered AtaR A44-M88 wrapped around AtaT Y144F (encompassing a large interface of ~1,500 Å 2 ). AtaR A44-M88 is anchored to the surface of AtaT via four structural . d, Serial dilutions of overnight cultures of E. coli strains transformed with pBAD33 expressing ataT and pKK223-3 vector expressing ataR and the mutants ataR −3 , ataR −6 and ataR −9 , under repression or induction conditions (each resulting protein variant lacks the last three, six or nine C-terminal residues).
motifs-mt1 (β -strand), mt2 (α -helix), a proline-rich fragment (P-rich) and mt3 (α -helix) (Fig. 3a-g ). This large interface covers crucial functional spots of AtaT via mt1, mt2 and mt3. No electron density was observed in the binding site of ac-CoA.
The N-terminal mt1 motif, AtaR mt1 (residues R53-N57) shows a shocking secondary structure reshape. This fragment, observed as the N-terminal part of α -helix α 2 in AtaR, switches to a β -strand in the AtaT Y144F -AtaR A44-M88 complex (Figs. 2a and 3b-d) . In this ) that allow a multilayered regulation of AtaT. b, Secondary structure-based sequence alignment of the four structural motifs of AtaR antitoxins, involved in the neutralization of GNAT toxins predicted using Jpred. c, AtaR A44-M88 (in red and pink) wraps AtaT Y144F and interferes with the Met-tRNA fMet binding site (mapped on the electrostatic surface potential of AtaT) that bridges both domains and is characterized by a large electropositive patch. The different regulatory motifs of AtaR are labeled in the structure. Catalytic residue Y144 is indicated in italic. d-g, Details of the neutralization interface involving the AtaR mt1 (d), AtaR mt2 (e), P-rich (f) and AtaR mt1 (g). The side chains of the interface residues are labeled (in red for the AtaR motifs and in black for AtaT) and shown as sticks. h, Structure of AtaR A44-M88 -AtaT Y144F bound to ac-CoA. Acetyl-CoA as observed in the AtaT Y144F -ac-CoA complex is superimposed on the structure (shown in pink). The presence of AtaR A44-M88 misaligns ac-CoA, flipping the pantetheine arm of ac-CoA almost 180° away from the active site.
bound form, AtaR mt1 forms a parallel β -strand with β 3 of the central β -sheet of AtaT interrupting the connexion between the positive region of AtaT involved in Met-tRNA fMet binding and the active site of the enzyme where acetyl group of ac-CoA binds. AtaR S60-M88 (that lacks AtaR mt1 ) is still able to neutralize AtaT in vitro, however, it binds to AtaT Y144F with ~2.5-fold lower affinity than AtaR A44-M88 (Supplementary Fig. 2i and Supplementary Table 1), suggesting AtaR mt1 has a supporting role in neutralization (Fig. 2c ). The central neutralization motif is an α -helix involving residues E58-S69 (AtaR mt2 ) that binds between the β 3-β 4 hairpin, β -strand β 5 and the loop α 3-β 5 ( Fig. 3b,c) . AtaR mt2 interacts with several residues of AtaT crucial for tRNA binding including R71 (Fig. 3e) . Moreover, in the bound form it notably changes the surface charge distribution of this region that probably plays an important role in aa-tRNA recognition. AtaR mt1 and AtaR mt2 are observed in the structure of free AtaR as part of the long α -helix α 2 of the RHH fold that ends right after AtaR mt2 due to the presence of a conserved proline-rich (P-rich) motif connecting AtaR mt2 and AtaR
mt3
. The P-rich motif involves P71, P72 and P74 (Fig. 3b,f) and resembles the structure of P-rich motifs recognized by SH3 domains that aid assembly of protein complexes 27, 28 . In this case, the carbonyl group of AtaR is hydrogen-bonding S166 of AtaT instead of the typical W or Y hydrophobic side chains engaging proline-rich peptides. The pyrrolidine groups of P71, P72 and P74 make further contacts with hydrophobic pockets formed by α -helix α 4 of AtaT (Fig. 3f) . AtaR A44-M88 residues E76-G87 constitute the C-terminal α -helical motif (AtaR mt3 ). This motif interacts with a hydrophobic surface patch of AtaT directly connected with the site where the adenosine group of ac-CoA binds (Fig. 3b,c,g ). AtaR mt3 is an amphipathic α -helix that on binding buries L78, A83 and L85 in two hydrophobic cavities of AtaT (Fig. 3g ). In addition, K77, R84 and Q87 of AtaR ) are deleted, the effects on growth in vivo are severe (Fig. 2d ). This suggests that AtaR mt3 is also crucial for neutralization and regulation of the ataRT system. These structural observations strongly suggest that AtaR A44-M88 is sufficient to neutralize the activity of AtaT via a mechanism that targets simultaneously the interaction of the Met-ACC part of Met-tRNA fMet with the acetyl group of ac-CoA, the overall interaction of Met-tRNA fMet with AtaT and the interaction of ac-CoA with the enzyme. Moreover, secondary structure prediction with JPred 4 (http://www.compbio.dundee.ac.uk/jpred4) on eight other AtaR-like antitoxins detects the presence of the motifs in the neutralization domain of these antitoxins. Sequence analysis shows the typical low conservation of disordered regions; however, all four motifs are clearly present (Fig. 3b) suggesting the neutralization mechanism of AtaT-like toxins may be conserved. -AtaT Y144F complex revealed ac-CoA binds in a distorted conformation not compatible with catalysis ( Fig. 3h and Supplementary Fig. 4a,b) . The presence of AtaR mt3 leads to the decrease in affinity with K77 and R80 of AtaR mt3 pushing the adenosine group out of its binding site ( Fig. 3h and Supplementary Fig. 4a,b) . Although the 5′ pyrophosphate group binds in a nearly identical conformation to that observed in the ac-CoA-AtaT Y144F complex, the allosteric effect triggered by AtaR mt3 precludes the proper alignment of the pantetheine arm, that flips ~180° away from the active site (Fig. 3h) . This results in a catalytically inactive conformation of ac-CoA.
AtaR-AtaT composition varies as a function of AtaT.
The stoichiometry of type II toxin-antitoxin complexes is a defining aspect of the regulation of many of these toxin-antitoxin modules 11, 29 . We analyzed the AtaT-AtaR complex purified from E. coli by SEC, to determine the stoichiometry of the complex. We estimated the complex has a molecular weight of ~85 kDa, suggesting it is a heterohexamer composed of two toxins and four antitoxins (Fig. 4a) . In this configuration, the complex probably has two AtaR monomers that are not needed to neutralize AtaT and could potentially bind additional toxins.
ITC confirmed the heterohexameric AtaT-AtaR binds additional AtaT Y144F dimers with an affinity of 445 nM (Supplementary Fig. 2l and Supplementary Table 1) . However, SEC analysis of the complex post-ITC showed the incorporation of the AtaT Y144F dimers resulted in a complex with smaller molecular weight (~61 kDa) and an estimated 2:2 stoichiometry, consistent with a heterotetrameric complex (Fig. 4a ). This stoichiometry switch indicates the composition of AtaT-AtaR could vary as a function of the level of AtaT as observed for other toxin-antitoxin modules 11, 23, 30 suggesting toxin neutralization and operon transcription regulation are linked. AtaT modulates the interaction of AtaR with its operator. The operator of ataRT consist of two inverted repeats upstream its promoter, each containing an AtaR-binding box 10 (Supplementary  Table 2 ). We used EMSAs to monitor, in vitro, the interaction of AtaR and AtaT-AtaR complexes with a DNA fragment of 47 base pair (Supplementary Table 2 ) containing its operator region (Opr 47 ). The addition of AtaR to the operator causes a fuzzy shift of the operator DNA suggesting that AtaR interacts weakly with the DNA (Fig. 4b) . The addition of AtaT strengthens this interaction to a certain extent, however, above a 1:1 molar ratio the toxin induces the dissociation from the DNA (Fig. 4b) . The observed effects are the result of AtaR-AtaT interactions since AtaT alone does not bind Opr 47 (Supplementary Fig. 5 ).
We next performed EMSA measurements with AtaT-AtaR purified directly from E. coli. The addition of this complex produced a strong shift of Opr 47 resulting in a clear and sharp DNA retardation (Fig. 4c) . ITC confirmed the EMSA results and shows that AtaTAtaR formed in vivo binds specifically the operator with an affinity of 176 nM ( Supplementary Fig. 2m and Supplementary Table 1) . Thus, it becomes apparent this complex interacts stronger with Opr 47 than the species reconstituted from AtaR and the AtaT Y144F dimer. Further addition of AtaT Y144F also led to the dissociation from Opr 47 as observed in Fig. 4c . Overall, these results indicate that AtaT-AtaR formed in the cell has a different composition to that reconstituted in vitro.
Structure of the AtaT-AtaR-operator complex. Coupling between toxin-antitoxin neutralization, translation and transcription regulation has long been suggested (although never proved) for type II toxin-antitoxin modules. Given the tight complex formed between toxin and antitoxin and that in most systems antitoxins are translated first, it is likely that toxin neutralization occurs as it is translated.
To further investigate this, we probed the regulation of the ataRT module in vivo and determined the structure of the linchpin of this regulatory process for the ataRT module, the complex between AtaT-AtaR and the operator DNA. The structure shows a two toxins: four antitoxins stoichiometry as estimated by SEC ( Fig. 5a and Supplementary Fig. 6a ), bound to a 22-base-pair operator fragment (Fig. 5b ) that contains two AtaR-binding boxes (Opr 22 ). The complex has an internal twofold symmetry with two antitoxin dimers interacting with Opr 22 via the RHH dimer. The N-terminal β -strand from each AtaR monomer (residues Q7 to L13), not visible in the structure of AtaR (Fig. 2a) , becomes ordered on binding to Opr 22 (Fig. 5c,d) . A β -strand from each monomer interacts in an antiparallel way and locks into the major groove of the DNA reading the GTCA recognition sequence (Fig. 5e) . The result of both AtaR dimers engaging Opr 22 is a slight bend of the DNA duplex (5° inward from the main axis). These interactions with the major groove explain the specificity of AtaR for its operator. Residues K6 and D10 interact specifically with bases G3, A5 and C6 of the operator via hydrogen bonds. R8 and R12 together with S33 from α -helix α 2 interact with the phosphodiester backbone of the DNA with K6 and R8 providing additional van der Waals contacts to T4 (Fig. 5e ). This particular arrangement of each AtaR dimer with respect to the major groove is reminiscent of that of the phage repressor Arc binding to its operator 31 . Perhaps more surprisingly the AtaT-AtaR 2 -Opr 22 -AtaR 2 -AtaT complex reveals AtaT in a monomeric state (Fig. 5a ,f) interacting with the C-terminal extension of AtaR, not involved in neutralization. In this conformation AtaT retains the GNAT fold; however, the regions including residues K77-P84 and R51-V58 become disordered (Fig. 5f ). Each AtaT monomer together with the AtaR monomers not involved in neutralization, form a structural scaffolding ( Supplementary Fig. 6b ) with AtaR projected toward a symmetry-related AtaT molecule and interacting with it at a different site (Fig. 5a,g ). The dimensions of this rhomboid structure are determined by α -helices α 1 and α 2 of AtaR ( Fig. 5a and Supplementary Fig. 6b ). In this arrangement, the C terminus of one toxin-antitoxin (TA 2 ) heterotrimer is effectively cross-linking the complex (in a non-covalent way) and protecting it from dissociation ( Supplementary Fig. 6b ). This also further stabilizes the monomeric form of AtaT, precluding dimerization. More importantly, this molecular framework positions the two AtaR dimers at an ideal distance compatible with the two inverted repeats of the operator (Supplementary Fig. 6b ).
In AtaT-AtaR 2 -Opr 22 -AtaR 2 -AtaT, the main AtaR-AtaT interaction site is identical to the conformation observed in the complex between AtaR A44-M88 and AtaT Y144F (Figs. 3d-g and 5a ,h) in agreement with AtaR A44-M88 binding monomeric and dimeric forms of AtaT with similar affinities (Supplementary Fig. 2n and Supplementary Table 1 ). However, in the second interaction site AtaR retains an α -helical conformation reminiscent of that from the structure of the free AtaR, and contacts toward the C terminus, the symmetryrelated AtaT monomer (Fig. 5c,g ). This interaction involves a small interface of 437Å 2 that includes residues V64 to S69 of AtaR and the C-terminal region of α -helix α 2 and β -strand β 2 of AtaT (Fig. 5g) . In all likelihood, these two conformations of the AtaR IDR result from the interaction of AtaR with different regions of AtaT.
The AtaT-neutralization mechanism primarily involves blocking functional sites of the enzyme, while from the composition of AtaT-AtaR 2 -Opr 22 -AtaR 2 -AtaT it becomes apparent that precluding AtaT dimerization is crucial for repression. This is probably achieved during AtaT synthesis establishing a double barrier to the toxin activation. In addition, binding to AtaT provides further stabilization to AtaR and facilitates the interaction with DNA (Fig. 4b,c) .
Heterohexameric AtaT-AtaR is stable in the absence of DNA. We used small-angle X-ray scattering (SAXS) coupled to SEC, to probe the conformational state of the AtaT-AtaR complex in solution. The complex has an oblate shape compatible with the conformation observed in the structure of AtaT-AtaR 2 -Opr 22 -AtaR 2 -AtaT. SAXS showed AtaT-AtaR has a molecular weight of ~77 kDa and R g of 34.3 Å (Supplementary Fig. 6c,d and Supplementary Table 3) in agreement with the SEC-multiangle light scattering characterization of AtaT-AtaR (Supplementary Fig. 6e ). This strongly suggests AtaT-AtaR adopts the heterohexameric arrangement observed in AtaT-AtaR 2 -Opr 22 -AtaR 2 -AtaT.
The reconstruction of AtaT-AtaR 2 -AtaR 2 -AtaT based on the structure of the heterohexameric complex bound to the DNA is already highly compatible with the ab initio envelope calculated from the SAXS data ( Supplementary Fig. 6d ). This model was further refined using molecular dynamics and a multistate modeling protocol implemented in MultiFoxS 32 to select the minimal ensemble with the best agreement to the experimental SAXS curves (Supplementary Fig. 6f ). These results highlight the flexibility of the complex in absence of DNA, particularly at the β -strand N terminus of AtaR and the monomeric form of AtaT. In addition, this structure suggests AtaT-AtaR 2 -AtaR 2 -AtaT is stable in solution and that AtaR is able to capture and neutralize AtaT before dimerization.
Transcription regulation by AtaT-AtaR in vivo. AtaR in vitro interacted weakly with the operator, the addition of the dimeric AtaT induced only a slight increase in affinity (Fig. 4b) . When the synthesis of AtaT was coupled to the neutralization by AtaR in the cell, the resulting AtaT-AtaR 2 -AtaR 2 -AtaT complex has the strongest affinity for DNA and further addition of AtaT dimers disrupted the binding leading to the formation of AtaT-AtaR complexes of ~60 kDa with a 2:2 stoichiometry (Fig. 4a) .
To validate these results we constructed a transcription-translation in vivo reporter system consisting of a unstable version of the green fluorescent protein (GFP-LVA) (~40 min in vivo) 33 introduced after the regulatory elements of the ataRT operon. The ataR antitoxin gene or the ataRT operon were then introduced on the inducible pBAD24 vector. In this design, the production of GFP-LVA on induction of AtaR, or the AtaT-AtaR complex is used as a proxy to assess the strength of the repression ( Supplementary Fig. 7a-f) .
As expected from the EMSA measurements, AtaR on its own could not repress the transcription of the reporter gene, however, AtaT-AtaR strongly repressed transcription. One hour after the expression of AtaT-AtaR, the GFP-LVA signal could not be detected anymore ( Supplementary Fig. 7a,b) . Based on the structure of AtaT-AtaR 2 -Opr 22 -AtaR 2 -AtaT we predicted residues K6, R8, D10, R12 and K18 from the β -strand β 1 and α -helix α 1 of AtaR would be crucial for DNA binding (Fig. 5e) . Indeed, D10A, R12A and K18G substitutions rendered the AtaRT complex inactive as a repressor whereas R8A retained ~50%, of the activity and K6A retained ~70% ( Supplementary Fig. 7b and Supplementary Table 4) .
These results suggest that β -strand β 1 is de facto reading the GTAC inverted repeat present in the operator. To confirm this, we mutated the GTCA binding box, which essentially disrupted the binding of AtaRT to DNA. EMSA experiments showed that even AtaT-AtaR could not bind the mutated DNA ( Supplementary  Fig. 8 ). ITC confirmed the specificity of AtaT-AtaR for this DNAbinding sequence and that this single mutation precluded DNA binding. (Supplementary Fig. 2o ,p and Supplementary Table 1) .
Operon repression requires the AtaT-AtaR heterohexamer. In AtaT-AtaR 2 -Opr 22 -AtaR 2 -AtaT (Fig. 5a ) the neutralized AtaT monomer works as a 'molecular ruler' that determines the relative orientation of the DNA-binding domains of AtaR (Fig. 5a-c) . The symmetry axis of both AtaR dimers, held together by AtaT, are separated by roughly 32 Å, matching the pitch of B-DNA, facilitating the interaction of both dimers with Opr 22 (Supplementary Fig. 9 ).
The AtaR monomer that is not involved in the neutralization of AtaT, is the one interacting with the neighboring toxin and provides additional contacts outside the hotspots targeted by motifs AtaR mt1 -AtaR mt3 . AtaR mt2 is directly involved in this interaction. Residues W61, V64, M65 and L68 of AtaR mt2 are making van der Waals interactions with AtaT at the dimer interface while AtaR mt1 remains in the α -helical state observed in the free form of AtaR (Figs. 2a and 5c ). This interaction seems crucial in preventing dimerization as it involves a large part of the dimer interface that is occupied by α -helix α 2 and β -strands β 4 and β 5.
AtaR also neutralizes the active dimeric form of AtaT. We propose that decoupling neutralization from transcriptional repression would have a strong impact on the regulatory process. Therefore, we introduced disrupting substitutions in AtaR mt2 to validate the role of this second interface and of AtaT as a molecular ruler, in the operon repression. The V64D substitution of AtaR impaired neutralization, however, L68D actively neutralized AtaT underlining both proteins could form a tight complex (Supplementary Fig. 7c ). We used the in vivo transcription-translation reporter as the ultimate measure of the activity of the AtaR L68D -AtaT complex (with the L68D substitution in AtaR mt2 ). The AtaR L68D -AtaT complex was not able to repress the transcription of GFP-LVA even though the substitution is away from the DNA-binding site (Fig. 5a ,g,h and Supplementary Fig. 7b ). This result underscores that full operon repression is entirely conditional to the formation of AtaT-AtaR 2 -Opr 22 -AtaR 2 -AtaT and directly linked to the neutralization of AtaT in a monomeric state.
Discussion
GNAT enzymes have a long history of association with aa-tRNAs. Staphylococcus aureus contains membrane-associated aminoacylated phosphatidylglycerol dependent on aa-tRNAs as aminoacyl donor 34, 35 , the enzyme catalyzing the transfer is a GNAT 36 . Homologous aa-tRNA-dependent GNATs also transfer Arg, Leu or Phe to the N terminus of proteins for degradation via the ClpS-ClpXP-mediated N-end rule 37 . Compared to these aa-tRNAdependent amino-acyl transferases, AtaT-like toxins represent an interesting twist of inversed catalysis with the aa-tRNA itself getting modified after the reaction 7 . Analogous substrate inversion has been also described in the Doc/Fic family of toxin-antitoxin toxins, resulting in new catalytic functions 38, 39 . Here we show how AtaR neutralizes the toxin AtaT in a unique way and how the complex autoregulates its transcription (Fig. 6) . We mapped Met-tRNA fMet -binding on the surface of AtaT, to a highly positive surface of the protein that involves the dimer interface and showed the activity of the toxin requires dimerization. AtaR neutralizes AtaT via four functional domains located mainly in the C-terminal IDR. These motifs are conserved in ataRT-like toxinantitoxins (in terms of secondary structural elements, as expected for IDRs in which the sequence identity is usually low), suggesting this neutralization mechanism of tRNA-modifying acetyl-transferases, has been retained in evolution.
Type II toxins and antitoxins seem to co-evolve toward maximizing the functionality of the system with a strong interconnection between neutralization, transcription and translation regulation. It has been suggested that type II antitoxins could neutralize toxins coupled to translation. Antitoxins can reverse the activity of the toxins, unlock a toxin-target complex or even induce the degradation of the toxin 3, 40, 41 . Perhaps the most important hallmark of antitoxins is their rapid turnover by cellular proteases 3 . This guarantees certain physiological conditions or external stimuli could activate the toxins, leading to rapid growth arrest by their cellular effects 3 . The presence of an IDR in most type II antitoxins is clearly a crucial factor for degradation 11 . However, further experimental work is needed to understand how degradation contributes to toxin activation and transcriptional regulation, in the context of very stable toxin-antitoxin complexes.
A major discovery of this study is that AtaR binds to two different sites of the AtaT through its IDR, resulting in a heterohexamer complex with twofold symmetry that defines the entire regulatory mechanism. We show AtaR is a weak repressor and in absence of AtaT, the ataRT promoter is very active. The structure of AtaTAtaR 2 -Opr 22 -AtaR 2 -AtaT shows that besides stabilizing AtaR, each AtaT monomer is working as a molecular ruler that positions the DNA-binding domains of AtaR at an optimum binding distance and this co-repressor activity of AtaT is essential to switch-off transcription (Fig. 5a ). In the complex, the AtaR monomer not involved in neutralization, engages the symmetry-related AtaT at a second binding site. This non-covalent cross-linked complex involving two different interaction sites for AtaR and AtaT is crucial for repression. Non-covalent cross-linked complexes resembling AtaTAtaR 2 -AtaR 2 -AtaT (albeit with different stoichiometry), have been observed for unrelated toxin-antitoxin complexes. Indeed, the hetero-octamer C. crescentus architecture observed in the VapBC1 complex and the pseudo-symmetric heteropentamer arrangement of P1 Phd-Doc, are crucial for their interaction with DNA 30, 42 , suggesting that cross-linked arrangements may provide regulatory advantages for toxin-antitoxin modules.
The system has additional regulatory levels. AtaR neutralizes AtaT coupled to the translation of the toxin preventing its dimerization but is also capable of inhibiting the active dimeric form which ensures neutralization beyond the context of transcription regulation (Fig. 6) . The AtaT dimer also functions as a very efficient derepressor and once the dimer is formed, further association with AtaR results in non-repressive complexes. Increased levels of the AtaT dimer switch the stoichiometry of AtaT-AtaR from a heterohexamer to a heterotetramer with weaker affinity for DNA. Indeed, the incorporation of additional AtaT dimers via the detached AtaR C-terminal regions still present in AtaT-AtaR 2 -Opr 22 -AtaR 2 -AtaT, has a disruptive effect, interfering with the secondary interaction site between adjacent AtaT and AtaR units.
This allows AtaR to sense the excess of active AtaT dimers and react by triggering de-repression, which in turn allows the production of more AtaR to prevent toxicity. It also ensures only an AtaRAtaT complex of a certain stoichiometry can repress transcription, providing a conditional response to the regulatory process (Fig. 6) . We can speculate that these stoichiometric interplays in the antitoxin-toxin ratio are a form of epigenetics that may condition the phenotype of the offspring. This strategy has been independently selected several times during evolution, and different versions have been observed in unrelated toxin-antitoxin modules with the presence of an IDR as the common factor.
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Methods
Cloning and mutagenesis. The ataRT promoter was amplified from the E. coli O157:H7 EDL933 strain using the oligonucleotides F-Pata-SacI and R-PataBamHI and cloned in front of GFP-LVA in pPROBE-gfp-LVA vector via SacI and BamHI restriction sites. AtaR gene and its shorter derivatives was amplified using F-AtaR-Eco and R-AtaR-Hind oligonucleotides, AtaRT operon was amplified using F-AtaR-Eco and R-AtaT-Hind oligonucleotides (Supplementary Table 2 ) and were cloned to either pBAD24 or pKK223.3 vectors through EcoRI and HindIII sites. Mutations in pBAD24-ataR-ataT as well as those in pBAD33-ataT were introduced by amplifying the wild-type coding plasmid using forward primer encoding a mutation and 5′ end and reverse primer listed in Supplementary Table 2 , phosphorylating the PCR product and circularizing it with T4 DNA ligase. For expression and purification, the mutated ataT derivatives were cloned pET28 vector in fusion with 6his-TEV tag. Mutated AtaT genes were amplified from respective pBAD33-ataT-mutant vectors using oligos F-ataT-Bmt and R-ataT-Xho. The pET28b plasmid was amplified with R-pET-hisTEV-Bmt and F-pET-synth to replace thrombin site for a Tobacco Etch Virus (TEV) protease site. Both amplicons were digested with BmtI and XhoI and ligated. All plasmids were transformed into E. coli DJ624Δ ara strain and correct clones were confirmed by sequencing. For expression pET28b vector derivatives were then transformed to BL21(DE3) strain.
Protein production and purification. Expression and purification of the AtaR-AtaT complex from the pKK223.3 vector as well as AtaR, AtaT Y144F , the AtaT Y144F -AtaR A44-M88 complex and the AtaR-AtaT-Opr 22 complex was done as described 10 . Mutated AtaT protein versions were purified using the same principle. For crystallization, ITC and EMSAs His-TEV tag was cleaved with recombinant his-TEV protease in a 100:1 molar ratio at 10 °C for 12 h. The removal of the Histag was confirmed by SDS-PAGE and western blot (using an anti-polyhistidine antibody, Sigma H1029). The excess of his-TEV protease was then removed by flushing the sample metal affinity column and further purified by gel filtration using either Superdex 200 HR or Superdex75 HR columns.
Crystallization. Crystallization conditions were screened by sitting-drop vapor diffusion at 277 K and 293 K for all protein samples (toxin, toxin-antitoxin, toxin-antitoxic peptide, toxin-antitoxin and DNA complexes). High throughput screening of conditions was performed with a Mosquito HTS system (TTP Labtech). Drops consisting of 100 nl of the target molecule solution (at concentrations between 10 mg ml −1 and 15 mg ml
) and 100 nl precipitant solution were equilibrated against 80 µ l of commercial crystallization screens (Crystal Screen I&II (Hampton Research), JCSG + , ProPlex, PACT Premier, Helix, LMB, Morpheus II (Molecular Dimensions)). Data were collected at the PROXIMA-1 (PX1) and PROXIMA-2A (PX2A) beamlines at the SOLEIL synchrotron (Gif-surYvette, Paris, France) and Id-24 Diamond Light Source synchrotron (Oxfordshire). All crystals were vitrified in liquid N 2 and stored in liquid N 2 for transport and data collection. The data sets from the AtaR crystals and the AtaR-AtaT-DNA crystals were collected at PX1 using PILATUS 6 M detector and the data sets from the AtaT and the AtaT Y144F -AtaR 44-88 crystals were collected at PX2A using an Eiger detector. All data were indexed, integrated with XDS 43 and scaled with XSCALE 43 or Aimless 44 . Data quality and twinning was assessed with phenix.xtriage 45 and Pointless
44
, Supplementary Table 5 details all the collection and processing statistics.
Structure determination. The Se-Met
AtaR crystals diffracted on average to ~3.8 Å. We performed a Se K-edge scan that showed a maximum at 0.9793 and we used this wavelength to collect the data for Single-wavelength anomalous diffraction (SAD)-phasing. The analysis of the data with ShelxC shows there is strong anomalous signal to around ~6.0 Å. ShelxD detected two heavy atoms with high occupancy, which was consistent with one AtaR chain in the asymmetric unit. This corresponds to a solvent content of ~0.6 as estimated with Matthews_Coeff. We used this solvent content for phasing and density modification with ShelxE
46
. The initial map calculated with ShelxE was of high quality and allowed the automatic tracing at 3.8 Å, of roughly 48 residues from the N-terminal DNA-binding domain of AtaR. This corresponds to most of the structured part of AtaR (the C-terminal part of the protein is predicted as disordered). This model was used as a molecular replacement search model for the higher resolution data set (2.9 Å) collected at Diamond Light Source and combined with Rosetta as implemented in the MRRosetta suit from the Phenix package. MR-Rosetta could trace AtaR from residues 13-65. After several iterations of manual building with Coot and maximum likelihood refinement as implemented in Buster/TNT, the model was extended to cover from residues 10-71 with the missing residues disordered in the structure, as observed in other toxin-antitoxin antitoxins (R/Rfree of 23.4/26.6%).
In the case of AtaT Y144F , the crystals of the native protein diffracted to roughly 2.5 Å at a wavelength of 0.9801 Å. However, we could not grow Se-Met AtaT Y144F diffracting crystals and the crystals were destroyed after soaking in solutions containing heavy atoms. Therefore, we used the coordinates of TacT 4 as search model (29% sequence identity) for molecular replacement on the native data set (PDBID 5FVJ). We could find a solution in space group P6 5 22 using phaser. The solution contains one AtaT Y144F molecule in the asymmetric unit that forms a homodimer after applying crystallographic symmetry. As with AtaR, we used MR-Rosetta after molecular replacement. MR-Rosetta built the structure almost to completion and in the map resulting from MR-Rosetta, a clear density suggesting the presence of a bound ac-CoA molecule was observed. The structure was completed after several iterations of manual building with Coot and maximum likelihood refinement as implemented in Buster/TNT to an R/Rfree of 19.6/25.4%. Supplementary Table 5 details the refinement statistics.
The crystals of the AtaT Y144F -AtaR 44-88 complex diffracted to ~2.3 Å, we used the coordinates of the unbound AtaT Y144F as search and found a solution in space group P3 1 21 with two AtaT Y144F in the asymmetric unit with phaser. Automatic model building with Arp/Warp could completely reconstruct the C-terminal region of AtaR present in the complex and additional manual building with Coot and maximum likelihood refinement with Buster/TNT were used to complete the model to an R/Rfree of 19.6/23.6%. For the complex of AtaT Y144F -AtaR 44-88 -ac-CoA, the structure of the AtaT Y144F -AtaR 44-88 complex was used as search model in phaser and ac-CoA was modeled in the density observed after molecular replacement and initial refinement. The structure was completed after several iterations of manual building with Coot and maximum likelihood refinement with in Buster/TNT to an R/Rfree of 19.9/26.6%. Supplementary Table 5 details the refinement statistics.
For the AtaR-AtaT-DNA complex, we generated a model of the DNA duplex of the modified DNA with the Make-NA server (http://structure.usc. edu/make-na/), a web-based utility to create ideal DNA and RNA models using Nucleic Acid Builder and subsequently used this model for molecular replacement. Small-angle X-ray scattering. SAXS data were collected at the SWING beamline (Soleil synchrotron, France) on a Pilatus 2 M detector using the standard beamline setup in SEC (size exclusion) mode. The samples were prepared in 500 mM NaCl, 2 mM Tris (2-carboxyethyl)phosphine (TCEP) and 30 mM Tris-HCl pH 7.0. Frames showing radiation damage were removed before data analysis. The data were analyzed with the ATSAS and ScÅtter suites. For the SEC-SAXS we used a Shodex KW404-4F column coupled to an HPLC system, in front of the SAXS data collection capillary, to separate the excess non-complexed material and thus remove this source of background. The sample was passed at a flow rate of 0.2 ml min and the data collected at 10 °C. Radius of gyration (R g ) values were obtained from the Guinier approximation and the I 0 (scattering intensity at zero concentration by extrapolation to q = 0, as implemented in ATSAS).
SAXS-based models were, derived from the coordinates of the AtaR-AtaT complex as observed in the complex with DNA. The coordinates of the initial model were completed to account for missing loops and side chains using Modeller. Furthermore, all SAXS models were relaxed by molecular dynamics equilibration at 300 K, and sampling from the trajectory generated an initial ensemble of a few thousand models. We then used a multistate modeling with SAXS profiles as implemented in MultiFoxS to select from this pool of structures the minimal ensembles with the best agreement with the experimental SAXS scattering curves. The calculation of ab initio shapes on the basis of the scattering data was done with the program DAMMIF from the ATSAS package. Supplementary Table 3 shows all the SAXS-derived parameters.
Circular dichroism. The circular dichroism measurements were made on a Jasco J-715 spectropolarimeter using a 0.1 cm path length cuvette. The temperature of the cuvette was monitored and maintained using a Peltier element. The wavelength scan measurements were performed at 298 K, in 50 mM Tris (pH 7.5), 500 mM sodium chloride and 1 mM TCEP. The protein concentration used in the measurements was 0.08 mg ml −1 for AtaR, AtaR A44-M88 and AtaR S60-M88 and 0.2 mg ml −1 for AtaT Y144F and AtaT V126D . The molar residue ellipticities (θ , degrees cm 2 mol −1 ) were obtained from the raw data (θ, ellipticity) after correcting for the buffer solution, according to [θ ] = θM w /(ncl), where M w is the weight-averaged molecular mass, c is the mass concentration, l is the optical path length and n is the number of amino acid residues. For thermal unfolding AtaR and AtaR A44-M88 were used at 0.08 mg ml −1 . The scan rate used for the data collection was 1.0 °C per min and the temperature of the cuvette was monitored using a Peltier element. To probe the stability of both proteins and presence of a thermal-induced transition, the ellipticity was monitored at 222 nm as a proxy of the α -helical content. The data was analyzed as previously described 47 and the results are shown in Supplementary Fig. 3b. tRNA production and charging. tRNA fMet transcript was synthesized in vitro from synthetic double-stranded DNA oligonucleotide (Sigma-Aldrich) listed in Supplementary Table 2. Sense and antisense oligonucleotides were mixed together, heated at 95 °C for 5 min and allowed to cool down at room temperature. T7 transcription reaction contained 2.5 µ M DTT, 0.25% Triton X, 30 mM MgCl 2 , 1.5 mM of each rNTP, 0.5 µ M dsDNA template, 0.5 µ M T7 polymerase and 0.1 µ M pyrophosphatase in reaction buffer (40 mM Tris-HCl pH 7.9, 6 mM MgCl 2 , 2 mM spermidine). Synthesis was allowed for 3 h, then tRNA was loaded on MonoQ anion exchange column in buffer A (20 mM HEPES-KOH pH 7.5, 20 mM NaCl) and eluted with buffer B (20 mM HEPES-KOH pH 7.5, 1.02 M NaCl). Fractions containing tRNA were then desalted by dialysis. tRNA fMet charging reaction for contained 20 µ M tRNA, 2 mM l-methionine, 0.5 mM adenosine tri-phosphate and 0.2 µ M MetRS in reaction buffer (50 mM HEPES-KOH pH 7.5, 10 mM KCl, 1 mM DTT, 20 mM MgCl 2 ). After 2 h of reaction 0.3 M sodium acetate pH 5.2 was added and tRNA was purified on size exclusion gel filtration Superdex75 column.
In vivo toxicity assays. E. coli DJ624Δ ara strains were transformed with pBAD33 vectors encoding ataT or ataT mutants. For toxicity compensation assays pKK223.3 vector encoding antitoxin or its mutants was co-transformed. For toxicity compensation in context of an operon DJ624Δ ara strain was transformed with pBAD24-ataRT or its mutants in the ataR gene. Overnight cultures in LB medium supplemented with appropriate antibiotics and 1% glucose were diluted serially (tenfold) and 10 μ l of dilutions were spotted on solid LB plates supplied with antibiotics and 0.2% glucose (repression conditions) or 0.2% arabinose (induction conditions). Plates were incubated overnight at 37 °C.
In vitro translation assays. In vitro translation assays were performed using PURExpress (NEB) coupled transcription-translation system. Reactions were supplied with 250 ng of DNA fragments containing T7 promoter and genes of interest obtained by PCR using primers listed in Supplementary Table 2 . PCR products were purified by phenol-chloroform extraction and ethanol precipitation, visualized on 2% agarose gel and quantified by absorption at 260 nm. Translation of peptides was visualized by separating the reaction mixture on 16% Tricine gel and staining with Coommassie blue. For translation inhibition assays, in vitro produced AtaT toxin was mixed with fivefold excess of translation reaction where peptides were produced and incubated for 15 min RT. Toxin or toxin-peptide mixtures were then added to reactions where translation of the reporter protein (GFP-strepII) was followed by western blot using antibodies against strepII affinity tag.
ITC. All ITC titrations were carried out on an Affinity ITC (TA Instruments). Before the measurement, proteins and nucleic acids were dialyzed in the same buffers. Protein-protein, protein-peptide and protein-coenzyme interactions were measured in 50 mM Tris-HCl pH 8.5, 500 mM NaCl, 1 mM TCEP at 25 °C. Protein-DNA interactions were measured in 50 mM Tris-HCl pH 8.5, 100 mM NaCl at 10 °C. Protein-RNA interactions were measured in 50 mM MES pH 6.5, 100 mM NaCl, 1 mM MgCl, 1 mM TCEP at 10 °C. The samples were filtered and degassed for 10 min before being examined in the calorimeter. All the experiments consisted of injection of constant volumes of 2 μ l of titrant into the cell (170 μ l) with a stirring rate of 75 r.p.m. Nominal sample concentrations were between 2 μ M and 15 μ M in the cell and 20 μ M to 150 μ M in the syringe. Sample concentrations were determined after dialysis or buffer exchange by measurement of their absorption at 280 nm for proteins and peptides, or at 260 nm for nucleic acids. All data were analyzed using the NanoAnalyze and Origin 7.0. Supplementary Table 1 reports the affinities measured for all the interactions.
EMSAs. The DNA fragments used for EMSAs are listed in Supplementary  Table 2 . The DNA duplexes were reconstituted from synthetic single stranded oligonucleotides (Sigma) that were annealed by heating to 95 °C and cooling at room temperature. The EMSA titrations contained 0.5 µ M of dsDNA and increasing amounts of proteins in 10 mM phosphate pH 8, 300 mM NaCl, 2.7 mM KCl, 10 mM Na 2 HPO 4 , 1.8 mM KH 2 PO 4 . The mixtures were incubated 30 min room temperature, then for 10 min on ice. Samples were mixed with loading buffer (50% glycerol, 10 mM Tris-HCl pH 8.0, 0,1% Nonidet, 1 mM DTT, 62.5 µ g ml −1 bromphenol blue) in a ratio of 1:5 and separated on 7% TBE gel. The acrylamide gel was pre-run for 30 min at 120 V with TBE buffer at 4 °C before loading the samples. Separation was started at 180 V for 10 min and continued for 40 min at 120 V at 4 °C. The resulting gel was then stained with ethidium bromide for 10 min and visualized under ultraviolet light at 302 nm.
Flow cytometry. DJ624Δ ara strain was transformed with pPROBE-Pata-gfp-LVA vector and pBAD24 vector and derivatives containing ataR gene and ataRT operon wild type or mutated in ataR gene. Strains were grown in M9 minimal medium with casamino acids, antibiotics (50 μ g ml −1 kanamycin, 100 μ g ml −1 ampicillin) and 0.2% glucose. At an absorbance A 600 nm of 0.4 expression of proteins from pBAD24 genes was induced by addition of 0.2% arabinose. Measurements were taken before induction and 1 h post-induction. For measurements cells were diluted to 0.05 of A 600 nm and analyzed with Attune NxT flow cytometer (Life Technologies). In the assay, 75,000 of events were measured for GFP-LVA fluorescence (488-530/30) in Attune NxT instrument (Life Technologies). Each graph shows 40,000 gated events for single bacteria. Supplementary Table 4 shows the processing and analysis of the flow cytometry data.
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We described in our paper 5 crystal structures. 
